CD157: A NEW PROGNOSTIC MARKER IN OVARIAN CANCER

被引：0
|
作者：
Borghese, G. [1 ]
Lanzo, G. [1 ]
Benvenuto, R. [1 ]
Arisio, R. [1 ]
Katsaros, D. [1 ]
Volante, M. [2 ]
Rapa, I. [2 ]
Ortolan, E. [3 ]
Benedetto, C. [1 ]
Funaro, A. [3 ]
机构：
[1] Univ Turin, St Anna Hosp, Dept Surg Sci, Turin, Italy
[2] Univ Turin, Pathol Unit, Dept Clin & Biol Sci, San Luigi Hosp, Turin, Italy
[3] Univ Turin, Lab Immunogenet, Dept Med Sci, Turin, Italy
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [1] CD157: A New Prognostic and/or Predictive Marker in Ovarian Cancer? A Retrospective Study
    Lanzo, G.
    Borghese, G.
    Arisio, R.
    Katsaros, D.
    Volante, M.
    Rapa, I.
    Benedetto, C.
    Ortolan, E.
    Funaro, A.
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 208A - 209A
  • [2] Functional Role and Prognostic Significance of CD157 in Ovarian Carcinoma
    Ortolan, Erika
    Arisio, Riccardo
    Morone, Simona
    Bovino, Paola
    Lo-Buono, Nicola
    Nacci, Giulia
    Parrotta, Rossella
    Katsaros, Dionyssios
    Rapa, Ida
    Migliaretti, Giuseppe
    Ferrero, Enza
    Volante, Marco
    Funaro, Ada
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (15): : 1160 - 1177
  • [3] Involvement of CD157 in the Control of Ovarian Cancer Progression
    Lo Buono, N.
    Morone, S.
    Parrotta, R.
    Giacomino, A.
    Chiorino, G.
    Ostano, P.
    Mello-Grand, M.
    Funaro, A.
    Ortolan, E.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S106 - S107
  • [4] CD157 at the intersection between leukocyte trafficking and epithelial ovarian cancer invasion
    Lo Buono, Nicola
    Morone, Simona
    Giacomino, Alice
    Parrotta, Rossella
    Ferrero, Enza
    Malavasi, Fabio
    Ortolan, Erika
    Funaro, Ada
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2014, 19 : 366 - 378
  • [5] Clinical and biological significance of CD157 in ovarian carcinoma
    Funaro, A.
    Lo-Buono, N.
    Morone, S.
    Parrotta, R.
    Arisio, R.
    Ferrero, E.
    Katsaros, D.
    Rapa, I.
    Volante, M.
    Ortolan, E.
    FEBS JOURNAL, 2011, 278 : 59 - 59
  • [6] CD157 is a Novel Prognostic Marker of Malignant Pleural Mesothelioma Involved in the Control of Tumor Aggressiveness
    Giacomino, A.
    Morone, S.
    Parrotta, R.
    Lo Buono, N.
    Rapa, I.
    Righi, L.
    Volante, M.
    Ruffini, E.
    Ortolan, E.
    Funaro, A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S107 - S107
  • [7] CD157 in Ovarian Carcinoma: How Does It Help Us?
    Annunziata, Christina M.
    Birrer, Michael J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (15): : 1004 - 1005
  • [8] CD157 expression enhances invasiveness of ovarian cancer cells and induces a mesenchymal phenotype
    Lo Buono, N.
    Scianna, M.
    Bovino, P.
    Morone, S.
    Parrotta, R.
    Ferrero, E.
    Giverso, C.
    Preziosi, L.
    Malavasi, F.
    Funaro, A.
    Ortolan, E.
    FEBS JOURNAL, 2011, 278 : 218 - 219
  • [9] Overexpression of CD157 Contributes to Epithelial Ovarian Cancer Progression by Promoting Mesenchymal Differentiation
    Morone, Simona
    Lo-Buono, Nicola
    Parrotta, Rossella
    Giacomino, Alice
    Nacci, Giulia
    Brusco, Alfredo
    Larionov, Alexey
    Ostano, Paola
    Mello-Grand, Maurizia
    Chiorino, Giovanna
    Ortolan, Erika
    Funaro, Ada
    PLOS ONE, 2012, 7 (08):
  • [10] Re: CD157 in Ovarian Carcinoma: How Does It Help Us?
    Ortolan, Erika
    Ferrero, Enza
    Funaro, Ada
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (22):
12345